Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Gullibility test

The classification of "Accelerated Filer" is partially based on having a market value of $75 million or more, but less than $700 million on defined qualifying dates. This is for the purpose of meeting SEC filing deadlines.

This classification remains in place until such time that the market value, on defined qualifying dates, is less than $50 million, when for filing purposes it becomes a non-accelerated filer.

The filing status of a Company is irrelevant in determining if it qualifies under the "smaller reporting company" exemption which is based on the market value on defined qualifying dates.

Therefore, as PTSC's market valuation was under $75 million on the qualifying date of November 30, 2009, the end of its most recent second fiscal quarter, the exemption would be applicable, but it would still have to meet the "Accelerated Filer" deadlines as the market value was not under $50 million on that date.

I hope that my explanation has clarified the matter for you and would ask in return your opinion as to the point of nominating anyone until such time that Rule 14a-11 is applicable to PTSC shareholders.

Thank you.

.

.

.

Be well

Share
New Message
Please login to post a reply